Search results
Amgen stock soars on positive obesity drug update, analysts raise PT
Investing.com· 2 days agoAmgen stock soars on positive obesity drug update, analysts raise PT
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
AOL· 1 day agoAmgen's (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a peek ...
No belt-tightening for obesity meds with market set to swell 10-fold
dpa international via Yahoo Finance· 6 days agoGlobal sales of new so-called miracle drugs to counter obesity could expand from $10 billion to $100...
Wegovy, an injectable medication used to treat obesity, will now be available in Canada. Here's what...
Yahoo Canada Style· 2 days agoPerspectives Wegovy users are advised to modify their diet and exercise. (Image via Getty Images)...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 1 day agoIf Soranus of Ephesus were alive today he'd be mighty surprised. Like his modern-day counterparts in...
The Ozempic effect: How a weight loss wonder drug gobbled up an entire economy
New Hampshire Union Leader· 3 hours agoThere is no escaping Ozempic and Wegovy. The development of semaglutide, the key ingredient in the...
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Motley Fool via Yahoo Finance· 19 hours agoAs one of the most established BDCs in America, its borrowing costs are relatively low compared to...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 2 days agoAmgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early...
Obesity Causes, Risk Factors, Treatment, Statistics, Prevention
MedicineNet.com· 5 days agoWhat is the role of medication in the treatment of obesity? Medication treatment of obesity should be used only in patients who have health risks related ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug...